Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Gene therapy AMT-130 slowed Huntington’s progression by up to 75% in a small study, but results need larger trials for confirmation.
A gene therapy called AMT-130 slowed Huntington’s disease progression by up to 75% in a small, unreviewed study of 29 patients, with higher-dose recipients showing the most benefit over 36 months.
Delivered via brain surgery, the treatment reduced harmful huntingtin protein levels and nerve damage markers in spinal fluid, with improvements in movement, cognition, and daily function.
While well-tolerated, side effects were linked to the invasive procedure.
Experts caution that results are preliminary, based on external comparisons rather than a controlled trial, and require confirmation through larger studies before regulatory approval, which uniQure plans to seek in 2026.
La terapia génica AMT-130 desaceleró la progresión de Huntington hasta en un 75% en un estudio pequeño, pero los resultados necesitan ensayos más grandes para su confirmación.